Biotechnology and Business University College Dublin

Overview

The Biotechnology and Business programme at University College Dublin offers a unique multidisciplinary approach for students looking to bridge the gap between complex laboratory research and commercial enterprise. This intensive curriculum is specifically tailored for non-business graduates from life-science or chemistry backgrounds who aspire to become managers or entrepreneurs in high-tech environments. By integrating scientific rigour with professional business education, the course ensures that graduates can navigate the challenges of the modern technology-based economy.

Why Biotechnology and Business at University College Dublin?

This programme is the result of a prestigious collaboration between the UCD School of Biomolecular and Biomedical Science and the UCD Michael Smurfit Graduate Business School, which is recognised as Ireland’s leading business school. Students benefit from an environment that mirrors the industrial landscape, where Ireland serves as a global hub for the world's top biopharmaceutical companies. The curriculum is developed in direct consultation with industry employers to ensure that the skills taught are both relevant and highly sought after in the current market.

Tuition Fee Breakdown

• International fee: EUR 29100 per year
• European fee: EUR 16400 per year

Visit the Fees and Funding section for a breakdown in your local currency.

Syllabus

The curriculum provides a balanced mix of scientific modules and business-focused subjects. Modules may include:

• Professional Career Development
• Business of Biotechnology and Science
• Marketing Management
• Business Strategy
• Organisational Behaviour
• Corporate Finance
• Regulatory Affairs for Life Sciences
• Biotech Case Study
• Feasibility and Business Plan

Careers with Biotechnology and Business

Graduates are exceptionally well-positioned for diverse roles within the biotechnology and pharmaceutical industries, ranging from management and consultancy to venture capital. The programme’s focus on commercialisation and business planning allows students to develop professional connections with leading global organisations. Previous graduates have secured positions at prominent firms such as Abbott, Amgen, GSK, Johnson & Johnson, and MSD. Additionally, the skills acquired support those interested in investment analysis or launching their own science-based start-ups.